The future is now: Locating biomarkers for dementia

Biomedicine as Culture: Instrumental Practices, Technoscientific Knowledge, and New Modes of Life

Volumn , Issue , 2007, Pages 61-85

  Lock, Margaret ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955070032     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203941584     Document Type: Chapter

References (68)

1. Almqvist, Elisabeth, Shelin Adam, Maurice Bloch, Anne Fuller, Philip Welch, Debbie Eisenberg, Don Whelan, David Macgregor, Wendy Meschino, and Michael R. Hayden. 1997. Risk reversals in predictive testing of Huntington disease. American Journal of Human Genetics 61:945-52.
2. Angell, Marcia. 2004. The truth about the drug companies. New York Review of Books 51:52-58.
3. Armstrong, H. E. 1931. The Monds and chemical industry: A study in heredity. Nature 128:238.
4. Berg, Paul. 1991. All our collective ingenuity will be needed. Federation of American Societies for Experimental Biology 5:75-77.
5. Bertram, Lars, and Rudolph E. Tanzi. 2004. Alzheimer's disease: One disorder, too many genes? Human Molecular Genetics 13, no. R1: R135-R41.
6. Breitner, John C. 1999. The end of Alzheimer's disease? International Journal of Geriatric Psychiatry 14:577-86.
7. Champagne, F., and M. Meaney. 2001. Like mother, like daughter: Evidence for non-genomic transmission of parental behavior and stress responsivity. Progress in Brain Research 133:287-302.
8. Condit, C. M. 1999. How the public understands genetics: Non-deterministic and non-discriminatory interpretations of the "blueprint" metaphor. Public Understanding of Science 8:169-80.
9. Corbo, R. M., and R. Scacchi. 1999. Apolipoprotein E (APOE) allele distribution in the world. Is APOEε4 a 'thrifty' allele? Ann Hum Genet 63 (Pt 4): 301-10.
10. Cox, S., and W. McKellin. 1999. "There's this thing in our family": Predictive testing and the construction of risk for Huntington disease. In Sociological perspectives on the new genetics, edited by P. Conrad and J. Gabe. London: Blackwell.
11. Cupples, L. A., L. A. Farrer, A. D. Sadovnick, N. Relkin, P. Whitehouse, and R. C. Green. 2004. Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: The REVEAL study. Genetics in Medicine 6:192-96.
12. Daffner, Kirk R., and Leonard F. M. Scinto. 2000. Early diagnosis of Alzheimer's disease: An introduction. In Early diagnosis of Alzheimer's disease, edited by L. F. M. Scinto and K. R. Daffner. Totowa, NJ: Humana Press.
13. Davis, B. D. 1990. The human genome and other initiatives. Science 4:2941-42.
14. DeKosky, Steven T., and Kenneth Marek. 2003. Looking backward to move forward: Early detection of neurodegenerative disorders. Science, 302:830-34.
15. Dennet, Daniel Clement. 1995. Darwin's dangerous idea: Evolution and the meanings of life. New York: Simon & Schuster.
16. Duster, Troy. 1990. Back door to eugenics. New York: Routledge.
17. Dutton, Gail. 2003. Learning the secrets of life. Engineering News 23:6-57.
18. Eddy, Sean R. 2001. Non-coding RNA genes and the modern RNA world. Nature Reviews/Genetics 2:919-29.
19. Farlow, Martin R. 1997. Alzheimer's disease: Clinical implications of the Apolipoprotein E genotype. Neurology 48:S30.
20. Fox Keller, Evelyn. 2000a. Is there an organism in this text? In Controlling our destinies: Historical, philosophical, ethical, and theological perspectives on the HGP, edited by P. Sloan. South Bend, IN: Notre Dame University Press.
21. Fox Keller, Evelyn. 2000b. The century of the gene. Cambridge, MA: Harvard University Press.
22. Fox Keller, Evelyn. 2002. Making sense of life: Explaining biological development with models, metaphors and machines. Cambridge, MA: Harvard University Press.
23. Gibbs, W. Wayt. 2003. The unseen genome: Gems among the junk. Scientific American 289, no. 5: 47-53.
24. Gilbert, Scott F. 2002. The genome in its ecological context: Philosophical perspectives on interspecies epigenesis. Annals of the New York Academy of Sciences 981:202-18.
25. Gottesman, I. I., and J. Shields. 1972. Schizophrenia and genetics: A twin study vantage point. New York: Academic Press.
26. Gottesman, Irving. 1994. Schizophrenia epigenesis: Past, present and future. Acta Psychiatrica Scandinavia 90, no. 384: S26-S33.
27. Grady, Denise. 2004. Nominal benefits seen in drugs for Alzheimer's. New York Times, April 7.
28. Gudding, Gabriel. 1996. The phenotype/genotype distinction and the disappearance of the body. Journal of the History of Ideas 57, no. 3: 525-45.
29. Hill, Shirley. 1994. Managing sickle cell disease in low-income families. Philadelphia: Temple University Press.
30. Jacob, François, and Jacques Monod. 1961. Genetic regulatory mechanisms in the synthesis of proteins. Journal of Molecular Biology 3:316-56.
31. Johannsen, Wilhelm. 1923. Some remarks about units in heredity. Hereditas 4:133-41.
32. Kay, Lily E. 1993. The molecular vision of life: Caltech, the Rockefeller foundation and the new biology. Oxford: Oxford University Press.
33. Kerr, A., S. Cunningham-Burley, and A. Amos. 1998. The new human genetics and health: Mobilizing lay expertise. Public Understanding of Science 7:41-60.
34. Kier, F. J., and V. Molinari. 2003. "Do-it-yourself" dementia testing: Issues regarding an Alzheimer's home screening test. Gerontologist 43:295-301.
35. Kitcher, Philip. 1996. The lives to come: The genetics revolution and human possibilities. New York: Simon & Schuster.
36. Konrad, Monica. 2005. Narrating the new predictive genetics: Ethics, ethnography and science. Cambridge Studies in Society and the Life Sciences, edited by N. Rose and P. Rabinow. Cambridge: University of Cambridge Press.
37. LeDoux, Joseph. 2002. Synaptic self: How our brains become who we are. London: Penguin Books.
38. Lewontin, Richard C. 2003. Science and simplicity. New York Review of Books 50, no. 7: 39-42.
39. Liddell, M. B., S. Lovestone, and M. J. Owen. 2001. Genetic risk of Alzheimer's disease: Advising relatives. British Journal of Psychiatry 178:7-11.
40. Lock, Margaret, Julia Freeman, Rosemary Sharples, and Stephanie Lloyd. 2006a. When it runs in the family: Putting susceptibility genes into perspective. Public Understanding of Science 15: 277-300.
41. Lock, Margaret, Stephanie Lloyd, and Janalyn Prest. 2006b. Genetic susceptibility and Alzheimer's disease: The "penetrance" and uptake of genetic knowledge. In Thinking about dementia: Culture, loss, and the anthropology of senility, edited by A. Leibing and L. Cohen, 123-56. New Brunswick, NJ: Rutgers University Press.
42. Maté, Gabor. 2004. Was that trademark smile the first sign of Alzheimer's? (London) Globe and Mail, June 12.
43. Mattick, John S. 2003. Challenging the dogma: The hidden layer of non-proteincoding RNAs in complex organisms. BioEssays 25:930-39.
44. Mattick, John S. 2004. The hidden genetic program of complex organisms. Scientific American 291:60-67.
45. McConnell, L. M., B. A. Koenig, H. T. Greely, and A. S. Raffin. 1998. Genetic testing and Alzheimer's disease: Has the time come?. Nature Medicine 4: 757-59.
46. Neumann, P. J., J. K. Hammitt, C. Muller, H. M. Fillit, J. Hill, N. A. Tetteh, and K. S. Kosik. 2001. Public attitudes about genetic testing for Alzheimer's disease. Health Affairs 20, no. 5: 252-64.
47. Novas, Carlos, and Nikolas Rose. 2000. Genetic risk and the birth of the somatic individual. Economy and Society 29:485-513.
48. Offit, Kenneth, Elizabeth Groeger, Sam Turner, Eve A. Wadsworth, and Mary A. Weiser. 2004. The "duty to warn" a patient's family member about heredity disease risks. Journal of the American Medical Association 292:1469-73.
49. Petronis, Arturas. 2001. Human morbid genetics revisited: Relevance of epigenetics. Trends in Genetics 17:142-46.
50. Pritchard, C., D. Baldwin, and A. Mayers. 2004. Changing patterns of adult (45-74 years) neurological deaths in the major Western countries 1979-1997. Public Health 118:268-83.
51. Rapp, Rayna. 1999. Testing women, testing the fetus: The social impact of amniocentesis in America. New York: Routledge.
52. Rheinberger, Hans-Jörg. 1995. From microsomes to ribosomes: "Strategies" of "Representation" 1935-1955. Journal of the History of Biology 28:49-89.
53. Richards, Martin. 1996. Lay and professional knowledge of genetics and inheritance. Public Understanding of Science 5:217-30.
54. Sapp, Jan. 1983. The struggle for authority in the field of heredity, 1900-1932: New perspectives on the rise of genetics. Journal of the History of Biology 16, no. 3: 311-42.
55. Schmiedeskamp, Mia. 2004. Preventing good brains from going bad. Scientific American 14:84-91.
56. Scinto, Leonard F., and Kirk R. Daffner, eds. 2000. Early Diagnosis of Alzheimer's Disease. Totawa, NJ: Humana Press.
57. Selkoe, Dennis J. 2002. The Pathophysiology of Alzheimer's Disease. In Early Diagnosis of Alzheimer's Disease. L. F. M. Scinto and K. R. Daffner, eds. Totawa, NJ: Humana Press.
58. Silver, M. H., K. Newell, E. T. Hedley-White, and T. T. Perls. 2001. Distinguishing between neurodegenerative disease and disease-free aging: Correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosomatic Medicine 64:493-501.
59. Snowdon, David. 2001. Aging with grace: What the nun study teaches us about leading longer, healthier, and more meaningful lives. New York: Bantam Books.
60. Stafford, Philip B. (1991). The social construction of Alzheimer's Disease. In Biosemiotics: The Semiotic Web, edited by Thomas A. Sebeok and Jean Umiker-Sebeok, 393-406 Berlin: Mouton de Gruyter.
61. St. George-Hyslop, P. H. 2000. Molecular genetics of Alzheimer's disease. Biological Psychiatry 47:183-99.
62. Swartz, R. H., S. E. Black, and P. St. George-Hyslop. 1999. ApolipoproteinE and Alzheimer's disease: A genetic, molecular and neuroimaging review. Canadian Journal of Neurological Sciences 26:77-88.
63. Thomas, A. Mathew, Gene Cohen, Robert M. Cook-Deegan, Joan O'Sullivan, Stephen G. Post, Allen D. Roses, Kennneth F. Schaffner, and Ronald M. Green. 1998. Alzheimer testing at silver years. Cambridge Quarterly of Healthcare Ethics 7:294-307.
64. Tilley, L., K. Morgan, and N. Kalsheker. 1998. Genetic risk factors in Alzheimer's disease. Journal of Clinical Pathology: Molecular Pathology 51:293-304.
65. Turney, Jon. 1995. The public understanding of genetics-Where next? European Journal of Genetics and Society 1:5-22.
66. Watson, James, and Francis Crick. 1953. The structure of DNA. Cold Spring Harbor Symposia on Quantitative Biology 18:123-31.
67. Whitehouse, Peter J. 2001. The end of Alzheimer disease. Alzheimer Disease and Associated Disorders 15, no. 2: 59-62.
68. Yates, Joshua. 2003. An interview with Ulrich Beck on fear and risk society. Hedgehog Review 5:96-107.